These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 5553356)

  • 21. [Proceedings: Differentiation of homozygote and heterozygote, therapy and follow-up study in 4 families with Wilson's disease].
    Abendschein Th; Przuntek H; Wesch H; Gäng V
    MMW Munch Med Wochenschr; 1975 May; 117(20):842. PubMed ID: 805973
    [No Abstract]   [Full Text] [Related]  

  • 22. [Early symptoms and early diagnosis in Wilson's disease].
    Przuntek H; Wesch H
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():678-80. PubMed ID: 1029259
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatolenticular degeneration. Clinical course in 2 siblings during penicillamine therapy].
    Højer-Pedersen E
    Ugeskr Laeger; 1979 Sep; 141(38):2610-1. PubMed ID: 483457
    [No Abstract]   [Full Text] [Related]  

  • 24. [Wilson's hepatolenticular degeneration. Apropos of a case report].
    Segal A; Ducasse A; Segal A
    Bull Soc Ophtalmol Fr; 1985 Jan; 85(1):129-31. PubMed ID: 4075480
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term body retention of radiocopper (67Cu) and the diagnosis of Wilson's disease.
    Willvonseder R; Goldstein NP; Tauxe WN
    Mayo Clin Proc; 1974 Jun; 49(6):387-93. PubMed ID: 4835809
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of penicillamine in Wilson-Konovalov disease].
    Vakharlovskiĭ VG; Nikitina LI; Bondarchuk AN
    Klin Med (Mosk); 1980 Jan; 58(1):56-60. PubMed ID: 7366142
    [No Abstract]   [Full Text] [Related]  

  • 27. [Wilson's disease (hepatolenticular degeneration)].
    Ferrer S; Grismali J; Vergara F; Madrid R; Colombo M
    Rev Med Chil; 1968 Dec; 96(12):779-88. PubMed ID: 5732518
    [No Abstract]   [Full Text] [Related]  

  • 28. [Complex medical and surgical treatment of hepatolenticular degeneration].
    Bondarchuk AN; Borodkin IuS; Vakharlovskiĭ VG; Neĭfakh SA; Smirnov VM
    Vopr Neirokhir; 1975; (1):40-4. PubMed ID: 1119126
    [No Abstract]   [Full Text] [Related]  

  • 29. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current problems of Wilson's disease (hepatolenticular degeneration)].
    Julesz J; Bodor F; Szarvas F
    Orv Hetil; 1969 Dec; 110(49):2857-60. PubMed ID: 5364763
    [No Abstract]   [Full Text] [Related]  

  • 31. Glucose intolerance in Wilson's disease. Normalization after treatment with penicillamine.
    Johansen K; Gregersen G
    Arch Intern Med; 1972 Apr; 129(4):587-90. PubMed ID: 5019448
    [No Abstract]   [Full Text] [Related]  

  • 32. [Early diagnosis and prevention of Wilson's disease].
    Arima M
    Saishin Igaku; 1969 Jun; 24(6):1219-25. PubMed ID: 5805577
    [No Abstract]   [Full Text] [Related]  

  • 33. [Test of stimulation of ceruloplasmin activity and copper concentration as affected by diphenylhydantoin (phenytoin, TSC) in the diagnosis of hepatolenticular degeneration].
    Pakszys W; Ligezińska B; Szymański H
    Pol Tyg Lek; 1982 Nov; 37(45):1353-7. PubMed ID: 7163091
    [No Abstract]   [Full Text] [Related]  

  • 34. D-penicillamine and plasmapheresis in acute liver failure secondary to Wilson's disease.
    Rodríguez Fariña E; Tremosa Llurba G; Xiol Quingles X; Lores Obradors A; Castellote Alonso J; Gornals Soler JB; López Núñez C
    Rev Esp Enferm Dig; 2003 Jan; 95(1):60-2, 63-5. PubMed ID: 12760731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On hepato-lenticular degeneration (Wilson's disease). I. Detection and early diagnosis].
    Campanella G; Gillardi U; Germinario L
    Acta Neurol (Napoli); 1971; 26(4):403-22. PubMed ID: 5132823
    [No Abstract]   [Full Text] [Related]  

  • 36. [The value of biochemical determination of copper in clinical diagnosis of hepatolenticular degeneration].
    Li NZ
    Zhonghua Yi Xue Za Zhi; 1983 Jun; 63(6):342-5. PubMed ID: 6414660
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of Wilson's disease by penicillamine?
    Lancet; 1968 May; 1(7550):1021-2. PubMed ID: 4171810
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pigment cirrhosis of the liver. I. Wilson's disease--hepatolenticular degeneration].
    Koziolowa H; Dziezbicka E
    Pol Arch Med Wewn; 1975 Nov; 54(5):491-5. PubMed ID: 1197060
    [No Abstract]   [Full Text] [Related]  

  • 39. Presymptomatic Wilson's disease.
    Levi AJ; Sherlock S; Scheuer PJ; Cumings JN
    Lancet; 1967 Sep; 2(7516):575-9. PubMed ID: 4166824
    [No Abstract]   [Full Text] [Related]  

  • 40. Wilson's disease: an update.
    Garg RK; Nag D
    J Assoc Physicians India; 1995 May; 43(5):351-5. PubMed ID: 9081968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.